Andrey Popatanasov | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Andrey Popatanasov | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Andrey Popatanasov |Institute of Neurobiology, Bulgarian Academy of Sciences | Bulgaria

Andrey Popatanasov is a dedicated and interdisciplinary Research Assistant at the Institute of Neurobiology, Bulgarian Academy of Sciences. With a unique academic foundation spanning Psychology, Physics, and Biology, Andrey brings a rare blend of scientific perspectives to his work. He has earned Master’s degrees in Clinical Psychology, Medical Physics, and Molecular Biology, and is currently finalizing his PhD in Human and Animal Physiology. His research focuses on the molecular basis of behavior, neurophysiology, and the effects of electromagnetic radiation on living systems. With over 10 publications, 2 books, and active involvement in 7 research projects, he has made notable contributions to our understanding of ligand-biomolecule interactions, genome regulation, and neurodevelopment in children. A member of three scientific societies, he remains committed to the pursuit of science that benefits both individuals and society. His integrative approach makes him a promising candidate for the Best Researcher Award.

Publication Profile: 

Scopus 

✅ Strengths for the Award:

  1. Multidisciplinary Education & Expertise

    • Holds BSc degrees in Psychology, Physics, and Biology, along with MSc degrees in Clinical Psychology, Medical Physics, and Molecular Biology – showcasing exceptional academic breadth.

    • Expected PhD in Human and Animal Physiology adds specialized depth to an already broad foundation.

  2. Research Productivity

    • 10 publications in recognized journals and 7 completed/ongoing research projects reflect active involvement in scientific work.

    • Books published with ISBN (two volumes) show his commitment to academic dissemination.

  3. Diverse Research Contributions

    • Strong focus on affective and prosocial behavior, genomic complexity, neurodevelopment, and electromagnetic radiation effects.

    • Combines in silico, in vitro, and behavioral methods – demonstrating scientific versatility.

  4. Institutional Engagement

    • Currently affiliated with the Institute of Neurobiology, Bulgarian Academy of Sciences, a reputable research body in Eastern Europe.

    • Active collaborations and membership in three professional societies validate professional integration.

  5. Ethical and Social Orientation

    • Expressed motivation to use science “for the benefit of our fellow human beings” aligns with the broader mission of responsible research.

⚙️ Areas for Improvement:

  1. Citation Impact

    • Citation index (3.5) is modest. While quality of research may be high, broader visibility and impact in the scientific community could be improved.

  2. Lack of Industry/Consultancy Involvement

    • No consultancy or industry-linked projects limits real-world application and knowledge transfer.

  3. Editorial/Leadership Roles

    • Absence of editorial appointments or scientific leadership roles (e.g., principal investigator, grant manager) suggests early-career status or limited exposure in scientific governance.

  4. Patent Activity

    • No patents filed or under process. Given his interdisciplinary research, potential for translational innovations is underutilized.

🎓 Education:

Andrey Popatanasov’s educational journey is both comprehensive and cross-disciplinary. He holds three Bachelor’s degrees in Psychology, Physics, and Biology, demonstrating early on his commitment to exploring the full spectrum of life and behavioral sciences. Building on this diverse base, he pursued three Master’s degrees in fields closely aligned with each undergraduate focus: Clinical Psychology, Medical Physics, and Molecular Biology. These degrees reflect his drive to merge theory with application, especially in fields involving human health, neuroscience, and molecular research. In 2025, he is expected to complete his PhD in Human and Animal Physiology, further enhancing his academic credentials. His educational background empowers him to approach research questions with a multidisciplinary lens, enabling innovative perspectives across cognitive sciences, neurobiology, and quantum biology. Andrey’s education sets a strong foundation for his integrative research and positions him as a well-rounded scholar capable of contributing meaningfully across scientific domains.

🧪 Experience:

Andrey Popatanasov’s professional experience has developed in tandem with his academic studies. While pursuing his degrees, he concurrently worked in several scientific institutes under the Bulgarian Academy of Sciences, contributing to both laboratory-based research and computational modeling. Currently, he serves as a Research Assistant at the Institute of Neurobiology, where he applies his multi-domain expertise to complex problems in neuroscience, molecular biology, and behavioral science. He has been actively involved in 7 research projects, authored 10 scientific articles, and published 2 academic books. His work includes studying neurobehavioral disorders, gene expression regulation, and the bioeffects of electromagnetic radiation. Despite not yet engaging in consultancy or industry collaborations, Andrey’s contributions in academic research have demonstrated both depth and societal relevance. Through interdisciplinary collaboration and ongoing PhD work, he continues to build a meaningful career rooted in both scientific rigor and human-focused inquiry.

🔬 Research Focus:

Andrey Popatanasov’s research spans several intersecting domains: neuroscience, molecular biology, biophysics, and psychology. His key focus areas include:

  • Affective and prosocial behavior, particularly in pathological states

  • Ligand interactions with biomolecules, explored through in silico and in vitro methods

  • Genomic complexity and expression control, with implications for cell physiology

  • Neurodevelopment in children, especially regarding language and cognitive processing

  • The impact of electromagnetic radiation, especially from quantum sources, on biological and soft matter systems

📚 Publication Top Notes:

  1. 📡 Electromagnetic Radiation Effects on Biomolecular Stability and Structure

  2. 🧬 Computational Modeling of Ligand-Receptor Dynamics in Neurological Systems

  3. 🧠 Behavioral and Molecular Correlates of Stress in Rodent Models

  4. 🧫 The Role of Genome Architecture in Gene Expression and Cell Function

  5. 👶 Language Complexity and Brain Function in Children with Neurodevelopmental Disorders

  6. 🤝 Multimodal Investigation of Prosocial Behavior and its Neural Basis

  7. 💥 Interaction of High-Energy Electromagnetic Fields with Soft Matter

  8. ⚛️ Quantum Radiation Exposure and its Biophysical Implications in Organic Systems

  9. 🧪 Receptor Binding Analysis through Molecular Dynamics Simulations

  10. 🔍 Bioinformatics-Based Comparative Study of Behavior-Linked Gene Expressions

📝 Conclusion:

Andrey Popatanasov is a highly promising researcher whose cross-disciplinary education, innovative scientific work, and integrative approach to research make him a strong candidate for the Best Researcher Award. While citation impact and industry engagement could be further developed, his commitment to foundational and applied research across neuroscience, psychology, and molecular biology stands out. His intellectual curiosity, publication record, and societal outlook reflect both scholarly excellence and a growth trajectory suitable for long-term scientific contribution.

Jin-Feng Hu | Molecular Mechanisms Signaling | Distinguished Scientist Award

Prof. Jin-Feng Hu | Molecular Mechanisms Signaling | Distinguished Scientist Award

Prof. Jin-Feng Hu , School of Pharmaceutical Sciences, Taizhou University, Zhejiang 318000, PR China ,China

Dr. Jin-Feng Hu is a globally recognized natural products chemist and currently serves as the Dean and Principal Investigator at the School of Pharmaceutical Sciences, Taizhou University, Zhejiang, China. With over three decades of academic and research experience, Dr. Hu has dedicated his career to discovering and developing bioactive natural products, particularly from rare and endangered plant species endemic to China. His contributions span innovative phytochemistry, drug discovery, and chemical biology. He has previously held prestigious academic positions at Fudan University and East China Normal University. Dr. Hu’s collaborations span continents, including Germany and the USA, contributing to an impressive international research profile. His work is widely published in high-impact journals and highly cited, underscoring the scientific relevance and translational potential of his discoveries.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Prolific Contributions to Natural Products Chemistry
    Dr. Hu has made significant breakthroughs in phytochemical research, particularly focusing on rare and endangered Chinese plants, contributing both to drug discovery and biodiversity conservation.

  2. Global Research Experience
    His training and postdoctoral fellowships in leading institutions across China, Germany, and the USA (including the Hans-Knoell-Institute and the Scripps Research Institute) add to his international reputation and collaborative strength.

  3. Academic Leadership & Institutional Impact
    As a former department chair at Fudan University and current Dean at Taizhou University, Dr. Hu has not only led cutting-edge research but also shaped the academic direction of major pharmaceutical programs.

  4. High-Impact Publications
    Multiple first or last-author papers published in leading journals such as Phytochemistry, Organic Chemistry Frontiers, Bioorganic Chemistry, and Molecules—with a focus on pharmacologically relevant compounds.

  5. Innovative Research Themes
    Focused on drug resistance, inflammation, and metabolic diseases, using unique molecules like bis-diterpene heterodimers and sesquiterpenes, often with novel skeletons—this shows originality and translational potential.

⚙️ Areas for Improvement:

  1. Wider Public Recognition
    While he is highly respected in academic and pharmaceutical chemistry circles, broader science communication or participation in international awards/societies could boost global visibility.

  2. Commercialization & Patents
    Encouraging the translation of discoveries into patents or clinical trials would further highlight the real-world impact of his research.

  3. International Grant Funding
    Expansion into multinational funding sources (e.g., NIH, EU Horizon) would solidify global research integration and amplify the scale of his discoveries.

🎓 Education:

Dr. Hu earned his B.S., M.S., and Ph.D. degrees in Organic Chemistry from Lanzhou University (1986–1996). He pursued advanced training and postdoctoral research in Natural Products Chemistry at the Institute of Materia Medica, Chinese Academy of Medical Sciences, followed by a prestigious BMBF Fellowship at the Hans-Knoell-Institute (HKI) in Germany. Dr. Hu then continued his postdoctoral work in the United States—first at the University of Mississippi focusing on natural products chemistry and later at the Genomics Institute of the Novartis Research Foundation/The Scripps Research Institute, in the laboratory of renowned chemist Prof. Peter G. Schultz. His academic journey across leading institutions in China, Germany, and the US provided a robust foundation in interdisciplinary sciences and global perspectives in medicinal chemistry.

🧪 Experience:

Dr. Hu currently serves as Full Professor, Principal Investigator, and Dean of the School of Pharmaceutical Sciences at Taizhou University (2021–present). Before this, he was Chair of the Department of Natural Products Chemistry at Fudan University (2011–2021), and prior to that, Deputy Director of the MOE Key Laboratory of Brain Functional Genomics at East China Normal University (2006–2011). In each position, he has led cutting-edge research in natural products, coordinated multi-institutional collaborations, mentored numerous young scientists, and managed institutional development. His lab integrates phytochemistry, structural biology, and drug discovery platforms, focusing particularly on therapeutic leads for antimicrobial resistance, cancer, and metabolic diseases. With a career that reflects both academic excellence and applied innovation, Dr. Hu has significantly contributed to China’s leadership in pharmaceutical science.

🏆 Awards and Honors:

Dr. Hu has received multiple national and international honors, including fellowships, research grants, and awards recognizing his excellence in natural products chemistry. He was a BMBF Research Fellow in Germany, a Postdoctoral Fellow at the Novartis Genomics Institute and The Scripps Research Institute in the US, and has been a recipient of several Chinese National Natural Science Foundation awards. His leadership roles at prestigious institutions like Fudan University and East China Normal University reflect the esteem he holds within the academic community. Moreover, his publications are widely cited, and his research frequently garners attention for its innovation and societal relevance, especially in the context of preserving biodiversity and discovering drugs from endangered species. These achievements make him an outstanding candidate for a Distinguished Scientist Award.

🔬 Research Focus:

Dr. Hu’s research is centered on the discovery and development of novel bioactive compounds from rare and endangered plants endemic to China. His work emphasizes the interface of phytochemistry, chemical biology, and drug discovery, employing integrative analytical techniques like NMR, LC-MS, and bioassays. A major focus is the identification of natural inhibitors of key metabolic enzymes such as ATP-citrate lyase and ACC1, with applications in metabolic disorders and cancer. His studies also target drug-resistant bacterial infections, inflammation, and neurodegenerative diseases. By studying plants that are ecologically valuable yet scientifically underexplored, Dr. Hu not only contributes to new therapeutic leads but also aids in conservation biology and chemotaxonomy. His approach of combining traditional Chinese medicinal knowledge with modern molecular science marks him as a trailblazer in natural products-based drug discovery.

📚 Publication Top Notes:

  1. 🌲 Spiroamentotaxols A−D from Amentotaxus yunnanensis and their bioactivitiesOrganic Chemistry Frontiers (2025)

  2. 🍃 Fortunefuroic acids from Keteleeria fortunei via integrated dereplication approachPhytochemistry (2025)

  3. 🌿 Benzofurans from Parrotia subaequalis with antimicrobial activityPhytochemistry (2025)

  4. 🌸 Bis-iridoid glycosides and triterpenoids from Kolkwitzia amabilis targeting ACC1 and ACLMolecules (2024)

  5. 🍂 Platanosides from Platanus acerifolia against drug-resistant infectionsBioorganic Chemistry (2024)

  6. 🌼 Natural products from Heptacodium miconioides and their classification significancePhytochemistry (2024)

  7. 🌲 Tsugaforrestiacids A–O from Tsuga forrestii with ATP-citrate lyase inhibitionPhytochemistry (2024)

  8. 🌲 Terpenoids from Pseudotsuga forrestii as DRAK2 inhibitorsJournal of Molecular Structure (2024)

  9. 🍁 Anti-inflammatory flavonoids from Platanus acerifolia leavesPhytochemistry Letters (2024)

  10. 🌴 Fortunefuroic acid J from Keteleeria hainanensis with dual inhibitory effectsChemistry & Biodiversity (2024)

🔚 Conclusion:

Dr. Jin-Feng Hu is an exceptionally qualified candidate for the Distinguished Scientist Award. His trailblazing research in natural products chemistry, strategic leadership in academic institutions, and commitment to preserving biodiversity through medicinal innovation position him as a thought leader in his field. His work not only expands the scientific frontier of phytochemical drug discovery but also addresses urgent global health concerns such as antibiotic resistance and metabolic disease. Recognizing Dr. Hu with this award would honor a career devoted to science, mentorship, and societal benefit, while also empowering his continued excellence in the years to come.